Hormone replacement therapy and breast cancer risk in a nationally representative cohort

American Journal of Preventive Medicine

Volumn 17, Issue 3, 1999, Pages 176-180

  Lando, James F ^a   Heck, Katherine E ^a   Brett, Kate M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; FAMILY HISTORY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; POSTMENOPAUSE;

EID: 0032865015     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(99)00078-1     Document Type: Article

References (23)

1. Brinton LA, Hoover RM, Szklo M, Fraumeni JF. Menopausal estrogen use and risk of breast cancer. Cancer 1981;47:2517-22.
2. Palmer JR, Rosenberg L, Clarke EA, Miller DR, Shapiro S. Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study. Am J Epidemiol 1991;134:1386-95.
3. Yang CP, Daling JR, Band PR, Galagher RP, White E, Weiss NS. Noncontraceptive hormone use and risk of breast cancer. Cancer Causes Control 1992;3:475-79.
4. Schairer C, Byrne C, Keyl PM, Brinton LA, Sturgeon SR, Hoover RN. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States). Cancer Causes Control 1994;5:491-500.
5. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
6. Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 1995;85:1128-32.
7. La Vecchia C, Negri E, Franchesci S, et al. Hormone replacement treatment and breast cancer risk: a cooperative Italian study. Br J Cancer 1995;72:244-8.
8. Lipworth L, Katsouyanni K, Stuverr S, Samoli E, Hankinson SE, Trichopoulos D. Oral contraceptives, menopausal estrogens, and the risk of breast cancer: a case-control study in Greece. Int J Cancer 1995;62:548-51.
9. Newcomb PA, Longnecker MP, Storer BE, et al. Long-term hormone replacement therapy and risk of postmenopausal breast cancer in postmenopausal women. Am J Epidemiol 1995;142:788-95.
10. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995;274: 137-42.
11. Schuurman AG, van den Brandt PA, Goldbohm RA. Exogenous hormones and the risk of postmenopausal breast cancer: results from the Netherlands cohort study. Cancer Causes Control 1995;6:416-24.
12. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent and prolong life in postmenopausal women. Ann Intern Med 1992;117(12): 1016-37.
13. Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991;151:67-72.
14. Steinberg KK, Thacker SB, Smith SJ, Zack MM, Flanders WD, Berkelman RL. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985-90.
15. Sillero-Arenas M, Delgado-Rodriguez M, Rodrigues-Canteras R, Bueno-Cavanillas A, Galvez-Vargas R. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 1992;79:286-94.
16. Henrich JB. The postmenopausal estrogen breast cancer controversy. JAMA 1992;268:1900-02.
17. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiologic studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-58.
18. National Center for Health Statistics. Plan and operation of the Health and Nutrition Examination Survey, United States, 1971-73. Rockville, MD: U.S. Department of Health, Education, and Welfare, 1976. Vital and Health Statistics, series 1, no. 10a. DHEW publication no (HRA) 76-1310.
19. National Center for Health Statistics, BB Cohen, HE Barbano, et al. Plan and operation of the NHANES I Epidemiologic Follow-up Study, 1982-84. Vital and Health Statistics. Public Health series 1, no. 22. Washington, DC: Government Printing Office, 1987. (DHHS publication no. (PHS) 87-1324).
20. SAS, version 6.12. Cary, NC: SAS Institute, Inc., 1996.
21. Miller BA, Ries LAG, Hankey BF, et al, eds. SEER Cancer Statistics Review: 1973-1990, National Cancer Institute. NIH Pub. No. 93-2789, 1993.
22. Egret Siz. Cambridge, MA: Cytel Software, 1997.
23. The Women's Health Initiative Study Group. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials 1998;19:61-109.